Tova Glaser

976 total citations
30 papers, 827 citations indexed

About

Tova Glaser is a scholar working on Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tova Glaser has authored 30 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cell Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tova Glaser's work include Calpain Protease Function and Regulation (10 papers), Blood properties and coagulation (6 papers) and Erythrocyte Function and Pathophysiology (5 papers). Tova Glaser is often cited by papers focused on Calpain Protease Function and Regulation (10 papers), Blood properties and coagulation (6 papers) and Erythrocyte Function and Pathophysiology (5 papers). Tova Glaser collaborates with scholars based in Israel, United States and Germany. Tova Glaser's co-authors include Nechama S. Kosower, Haim Werner, Sivia Barnoy, Shirley Abramovitch, Gila Idelman, Daniel Ayalon, Toru Ouchi, Charles T. Roberts, Isaac Cohen and Edward M. Kosower and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Tova Glaser

29 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tova Glaser Israel 17 482 305 163 131 116 30 827
L. Jorge Góñez Australia 15 578 1.2× 135 0.4× 52 0.3× 117 0.9× 203 1.8× 21 1.0k
Eva Landgren Sweden 16 548 1.1× 192 0.6× 25 0.2× 214 1.6× 182 1.6× 18 980
Carl-Henrik Heldin Sweden 7 478 1.0× 155 0.5× 53 0.3× 32 0.2× 65 0.6× 8 822
D O Lucas United States 10 336 0.7× 163 0.5× 32 0.2× 57 0.4× 58 0.5× 17 740
K. D. Brown Slovakia 10 241 0.5× 83 0.3× 51 0.3× 96 0.7× 113 1.0× 12 586
Lionel Rémy France 12 281 0.6× 107 0.4× 36 0.2× 96 0.7× 93 0.8× 29 614
Tomoko Tsuchiya Japan 17 471 1.0× 78 0.3× 55 0.3× 38 0.3× 85 0.7× 34 882
Elizabeth A. Waterman United Kingdom 16 187 0.4× 438 1.4× 45 0.3× 73 0.6× 56 0.5× 24 879
Kerstin Dehne Germany 11 471 1.0× 105 0.3× 38 0.2× 106 0.8× 38 0.3× 16 890
Katsumi Yamamori Japan 10 256 0.5× 86 0.3× 52 0.3× 94 0.7× 73 0.6× 11 635

Countries citing papers authored by Tova Glaser

Since Specialization
Citations

This map shows the geographic impact of Tova Glaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tova Glaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tova Glaser more than expected).

Fields of papers citing papers by Tova Glaser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tova Glaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tova Glaser. The network helps show where Tova Glaser may publish in the future.

Co-authorship network of co-authors of Tova Glaser

This figure shows the co-authorship network connecting the top 25 collaborators of Tova Glaser. A scholar is included among the top collaborators of Tova Glaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tova Glaser. Tova Glaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trebicz‐Geffen, Meirav, Dror Robinson, Tova Glaser, et al.. (2008). The molecular and cellular basis of exostosis formation in hereditary multiple exostoses. International Journal of Experimental Pathology. 89(5). 321–331. 31 indexed citations
2.
Shalita-Chesner, Michal, Tova Glaser, & Haim Werner. (2004). Signal Transducer and Activator of Transcription-1 (STAT1), but Not STAT5b, Regulates IGF-I Receptor Gene Expression in an Osteosarcoma Cell Line. Journal of Pediatric Endocrinology and Metabolism. 17(2). 211–8. 3 indexed citations
3.
Idelman, Gila, Tova Glaser, Charles T. Roberts, & Haim Werner. (2003). WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation. Journal of Biological Chemistry. 278(5). 3474–3482. 61 indexed citations
4.
Trebicz‐Geffen, Meirav, et al.. (2003). The short-lived exostosis induced surgically versus the lasting genetic hereditary multiple exostoses. Experimental and Molecular Pathology. 74(1). 40–48. 4 indexed citations
5.
Abramovitch, Shirley, Tova Glaser, Toru Ouchi, & Haim Werner. (2003). BRCA1–Sp1 interactions in transcriptional regulation of the IGF‐IR gene. FEBS Letters. 541(1-3). 149–154. 77 indexed citations
6.
Vigodner, Margarita, et al.. (2002). Use of confocal microscopy for the study of spermatogenesis. Methods in Cell Science. 24(4). 169–180. 5 indexed citations
7.
Glaser, Tova, et al.. (2002). Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein. Oncogene. 21(12). 1890–1898. 29 indexed citations
8.
Ayalon, Daniel, Tova Glaser, & Haim Werner. (2001). Transcriptional regulation of IGF-I receptor gene expression by the PAX3–FKHR oncoprotein. Growth Hormone & IGF Research. 11(5). 289–297. 68 indexed citations
9.
Kempf, Tore, et al.. (2001). Intracellular location and nuclear targeting of the Spi-1, Spi-2 and Spi-3 gene-derived serine protease inhibitors in non-secretory cells. European Journal of Cell Biology. 80(5). 341–348. 15 indexed citations
10.
Werner, Haim, et al.. (2000). Regulation of the Insulin-Like Growth Factor-I Receptor Gene by Oncogenes and Antioncogenes: Implications in Human Cancer. Molecular Genetics and Metabolism. 71(1-2). 315–320. 44 indexed citations
11.
Barnoy, Sivia, et al.. (1999). Association of calpain (Ca2‐dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts. Journal of Cellular Biochemistry. 74(4). 522–531. 8 indexed citations
12.
Barnoy, Sivia, Tova Glaser, & Nechama S. Kosower. (1998). The calpain–calpastatin system and protein degradation in fusing myoblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1402(1). 52–60. 61 indexed citations
13.
Malcov, Mira, Dalit Ben‐Yosef, Tova Glaser, & Ruth Shalgi. (1997). Changes in calpain during meiosis in the rat egg. Molecular Reproduction and Development. 48(1). 119–126. 15 indexed citations
14.
Barnoy, Sivia, Tova Glaser, & Nechama S. Kosower. (1997). Calpain and calpastatin in myoblast differentiation and fusion: Effects of inhibitors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1358(2). 181–188. 62 indexed citations
15.
16.
Glaser, Tova, et al.. (1994). Calpastatin in erythrocytes of young and old individuals. Biochemical Journal. 304(2). 365–370. 22 indexed citations
17.
Glaser, Tova, et al.. (1994). Calpain (Ca(2+)-dependent thiol protease) in erythrocytes of young and old individuals.. Proceedings of the National Academy of Sciences. 91(17). 7879–7883. 51 indexed citations
18.
Ravid, Amiram, et al.. (1994). 1,25-Dihydroxyvitamin D3 increases the cellular content of the calcium-activated neutral protease mu-calpain in renal cell carcinoma.. Endocrinology. 135(6). 2822–2825. 20 indexed citations
19.
Glaser, Tova, et al.. (1991). Band 3 protein degradation by calpain is enhanced in erythrocytes of old people. Biochemical Journal. 275(1). 47–52. 34 indexed citations
20.
Cohen, Isaac, et al.. (1975). Fibrin‐Blood Platelet Interaction in a Contracting Clot. British Journal of Haematology. 31(1). 45–50. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Jorge Góñez Breakdown of academic impact, for papers by Eva Landgren Breakdown of academic impact, for papers by Carl-Henrik Heldin Breakdown of academic impact, for papers by D O Lucas Breakdown of academic impact, for papers by K. D. Brown Breakdown of academic impact, for papers by Lionel Rémy Breakdown of academic impact, for papers by Tomoko Tsuchiya Breakdown of academic impact, for papers by Elizabeth A. Waterman Breakdown of academic impact, for papers by Kerstin Dehne Breakdown of academic impact, for papers by Katsumi Yamamori
Rankless by CCL
2026